NCT06746116
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06746116
Title A Study to Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in Spain (DUoENDE)
Acronym DUoENDE
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements Yes
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Research Site A Coruña 15006 Spain Details
Research Site Alicante 03010 Spain Details
Research Site Barakaldo 48903 Spain Details
Research Site Barcelona 08035 Spain Details
Research Site Córdoba 14004 Spain Details
Research Site El Palmar 30120 Spain Details
Research Site Girona 17007 Spain Details
Research Site L'Hospitalet de Llobregat 08908 Spain Details
Research Site Las Palmas de Gran Canaria 35016 Spain Details
Research Site Madrid 28034 Spain Details
Research Site Madrid 28041 Spain Details
Research Site Madrid 28046 Spain Details
Research Site Madrid 28807 Spain Details
Research Site Málaga 29010 Spain Details
Research Site Pamplona 31008 Spain Details
Research Site Salamanca 37007 Spain Details
Research Site San Sebastián 20014 Spain Details
Research Site Santander 39008 Spain Details
Research Site Seville 41013 Spain Details
Research Site Valencia 46009 Spain Details
Research Site Valencia 46010 Spain Details
Research Site Valencia 46026 Spain Details
Research Site Vigo 36312 Spain Details
Research Site Zaragoza 50009 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field